Security readout for executives and security teams
Plain-English summary
CVE-2026-21970 affects Oracle Life Sciences Central Designer 7.0.1.0. A low-privileged user with HTTP network access could gain unauthorized access to critical data, potentially all data the application can access. This is mainly a confidentiality risk, not a system takeover or outage issue based on the provided sources.
Executive priority
Prioritize if Central Designer stores regulated clinical, study, or trial design data. The issue can expose critical data but requires an authenticated low-privileged attacker. Treat as timely patching and access-control work rather than emergency response unless the system is broadly exposed.
Technical view
Oracle describes an easily exploitable Platform component vulnerability in Oracle Life Sciences Central Designer 7.0.1.0. CVSS 3.1 is 6.5: AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N. The attack requires network access over HTTP and low privileges, with high confidentiality impact and no stated integrity or availability impact.
Likely exposure
Exposure is likely limited to organizations running Oracle Life Sciences Central Designer 7.0.1.0, especially where authenticated users can reach the application over HTTP. Internet-facing or broadly accessible deployments increase concern. The sources do not identify other affected versions.
Exploitation context
The CVE states exploitation is easy and requires low privileges, network access via HTTP, and no user interaction. The provided bundle does not show CISA KEV listing, active exploitation, public exploit availability, or observed attacks.
Researcher notes
No CWE is provided in the source bundle. The only affected version named is 7.0.1.0. Do not assume code execution, privilege escalation, or data modification; the stated impact is confidentiality only. No active exploitation evidence is provided.
Mitigation direction
- Review Oracle's January 2026 Critical Patch Update guidance for this CVE.
- Patch or update affected Oracle Life Sciences Central Designer 7.0.1.0 systems per Oracle guidance.
- Restrict HTTP access to trusted networks and necessary users.
- Review low-privileged account access to Central Designer.
- Monitor for unusual access to sensitive study or clinical design data.
Validation and detection
- Inventory Oracle Life Sciences Central Designer deployments and versions.
- Confirm whether version 7.0.1.0 is present.
- Verify whether the application is reachable over HTTP from untrusted networks.
- Check Oracle advisory status for required updates or patches.
- Review access logs for unexpected data access by low-privileged users.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CVE-2026-21970 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Medium
- CVSS
- 6.5 (3.1)
- Known Exploited
- No
- Published
Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
CVSS vector scores
1 official scoreWe collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N2.83.6Primary CVE scoreVulnerability scoring details
Base CVSS 3.1 score
6.5MediumVector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
Source materials
- CVE List V5 sourceCVE List V5
- Oracle AdvisoryCVE reference · vendor-advisory
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.